1093759-49-9 Usage
General Description
1-(triisopropylsilyl)-1H-pyrrolo[2,3-b]pyridine is a chemical compound that is used as a building block in organic synthesis and medicinal chemistry. It is a substituted pyridine derivative with a triisopropylsilyl group attached to the nitrogen atom. 1-(triisopropylsilyl)-1H-pyrrolo[2,3-b]pyridine is known for its ability to serve as a versatile intermediate in the synthesis of various pharmaceuticals and agrochemicals. Its unique structure and reactivity make it a valuable tool for creating complex organic molecules, and it has been utilized in the development of potential drug candidates and other bioactive compounds. Additionally, the triisopropylsilyl group provides protection for the nitrogen atom, allowing for selective chemical transformations and enhancing the compound's stability during chemical reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 1093759-49-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,3,7,5 and 9 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1093759-49:
(9*1)+(8*0)+(7*9)+(6*3)+(5*7)+(4*5)+(3*9)+(2*4)+(1*9)=189
189 % 10 = 9
So 1093759-49-9 is a valid CAS Registry Number.
1093759-49-9Relevant articles and documents
Au-Catalyzed Cross-Coupling of Arenes via Double C-H Activation
Cambeiro, Xacobe C.,Ahlsten, Nanna,Larrosa, Igor
supporting information, p. 15636 - 15639 (2016/01/09)
The first methodology for Au(I/III)-catalyzed oxidative cross-coupling of arenes via double C-H activation has been developed. The reaction is fully selective for the cross-coupling between electron-rich hetero-/carbocyclic arenes and electron-poor arenes bearing relatively acidic C-H bonds. The inherently high cross-selectivity of the system obviates the need for directing groups or a large excess of one of the coupling partners.
AZAINDOLES USEFUL AS INHIBITORS OF ROCK AND OTHER PROTEIN KINASES
-
Page/Page column 180-189, (2008/06/13)
The present invention relates to compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
